| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56395c5d4f1126c9dd9cbe1b16b1de97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b640a6e02238d721260eb4c2ff06bdd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f381cbdf872308c26d18d884c08aed81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36a0c574cf1cc9f3357d3000fd63ebba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffff06f94237a26f3df264bd24c1de49 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 |
| filingDate |
2008-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b461b687f30e20958d8919853f45618b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_298edce571bb99a3bf48e82708e829d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a38236d74567c00570b8a44da3c8a71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c270825adeaf1a5ce295aa293b68b88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c299b3010e00771318156aa4add14553 |
| publicationDate |
2009-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009203660-A1 |
| titleOfInvention |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
| abstract |
Pharmaceutical compositions suitable for administration into the interior of an eye of a person or animal are described. The present compositions include one or more components which are effective in providing a reduced toxicity relative to existing intraocular ophthalmic compositions. The present compositions include one or more therapeutic agents in amounts effective in providing a desired therapeutic effect when placed in an eye, and one or more retinal friendly excipients that have a reduced toxicity relative to benzyl alcohol or polysorbate 80. In certain compositions, the excipient component of the compositions comprises one or more cyclodextrins or cyclodextrin derivatives. Methods of using the compositions to treat ocular conditions are also described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011070310-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9265775-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011020453-A1 |
| priorityDate |
2003-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |